CIPO2015: Optimizing Adoptive Immunotherapy for Cancer

(27:33)

CIPO2015: Durable Immune Control of ALL Requires a Multi-Antigen Immune Response

(15:2)

CIPO2015: Dual Targeting of CD19 \u0026 CD22 on B-ALL Using a Single Bispecific Chimeric Antigen Receptor

(11:22)

CIPO2015: Pre-clinical and Clinical Development of CD22-Targeted CAR T Cells

(16:28)

CIPO2015: Enhancing the IQ of CAR T Cells Using the Synthetic Biology Tool Box

(20:21)

CIPO2015: Adoptive T Cell Immunotherapy Targeting the Minor Histocompatibility Antigen HA-1

(15:2)

CIPO2015: Genetically Engineered Macrophages: Overcoming the Brain Tumor Microenvironment

(18:38)

CIPO2015: Effective Ablation of Chimeric Antigen Receptor-Modified T Cells for AML with Alemtuzumab

(15:49)

Testosterone Optimization. Low Testosterone Levels \u0026 Hypogonadism

(18:51)

CIPO2015: T Cells as Biotherapeutics for Solid Tumors

(28:28)

Optimizing Development in Early Phase: mTPI Case Study, Bayesian Adaptive Dose Finding Trials

(41:53)

12 5 Optimization corrected 11 09 2015

(18:9)

S.WOP - S.oftware for Wire Optimized Production

(3:15)

CIPO2015: Targeting GD2 w/ 3F8 \u0026 B7-H3 w/ 8H9: Lessons Learned \u0026 Next Generation Therapeutics

(33:10)

2 9 Physical Optimization 11 14

(11:15)

20FORCE Olsen A Machine Learning Approach to Optimizing the Allocation of Steam used in ConocoPhilli

(20:54)

CIPO2015: Anti-GD2 mAb and Next Generation mAb-Based Agents, KIR, Cytokines and Combination Therapy

(32:50)

Suvrajeet Sen (USC): Learning Enabled Optimization

(1:9:26)